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Two billion people are infected with
intestinal worms [1]. In many areas, the
majority of schoolchildren are infected,
and the World Health Organization
(WHO) has called for school-based mass
deworming. The key area for debate is not
whether deworming medicine works—in
fact, the medical literature finds that
treatment is highly effective [2], and thus
the standard of care calls for treating any
patient known to harbor an infection. As
the authors of the Cochrane systematic
review point out, a critical issue in
evaluating current soil-transmitted hel-
minth policies is whether the benefits of
deworming exceed the costs or whether it
would be more prudent to use the money
for other purposes [3].
While in general we think the Cochrane
approach is very valuable, we argue below
that many of the underlying studies of
deworming suffer from three critical meth-
odological problems: treatment externalities
in dynamic infection systems, inadequate
measurement of cognitive outcomes and
school attendance, and sampleattrition. We
then argue that the currently available
evidence from studies that address these
issues is consistent with the consensus view
expressed by other reviews and by policy-
makers that deworming is a very cost-
effective way to increase school participa-
tion and has a high benefit to cost ratio.
Treatment Externalities
Most of the studies included in David
Taylor-Robinson and colleagues’ system-
atic review do not adequately address the
population dynamics of helminth infec-
tion. These studies follow standard prac-
tice in clinical trials and consider untreat-
ed people as a control group. But
geohelminth transmission is a dynamic
process, and both theoretical and commu-
nity studies have shown that treatment of
some individuals leads to a reduction in
transmission in the community as a whole
[4,5]. Thus, in a trial randomized at the
level of the individual, the expected
difference between treatment and control
children within the same area will be less
than the actual treatment effect. If, for
example, school attendance increases by 8
percentage points among treated children
and by 4 percentage points among the
untreated due to externalities, the estimat-
ed impact using this technique will only be
4 percentage points, rather than the true
effect of 8 percentage points. These
concerns are not merely hypothetical: a
study in Kenya found large health and
educational spillovers to untreated stu-
dents within treated schools and even to
students in nearby schools [6]. In light of
this finding, the primary focus of a review
should be studies that use a cluster design
and correct standard errors for intra-
cluster correlation [6–8], if indeed the
purpose of such a review is to evaluate the
desirability of mass deworming as a policy.
The three studies cited which used this
approach, some of which were excluded
from the Cochrane review, did find
positive effects of deworming.
Measuring Cognitive Outcomes
and School Attendance
T h es u m m a r yo ft h eC o c h r a n er e v i e w[ 3 ]
published in this issue of PLoS Neglected
Tropical Diseases focuses on biomedical out-
comes while only touching on cognitive and
educational issues in a single paragraph.
Measuring the impact of a health
intervention on cognitive outcomes re-
quires careful consideration based on an
understanding of the nature of cognitive
development, and at least three issues need
to be addressed [9]. First, impaired
cognition rarely results from a single cause
[10]. Worm infections are likely to affect
children’s cognitive development different-
ly according to their levels of poverty,
psychosocial stimulation, and general
health status. Reporting of these other
environmental risk factors is essential for
interpreting studies on cognitive impacts,
yet such reporting is rarely used as an
inclusion criterion in systematic reviews.
Second, the cumulative and interacting
impacts of multiple threats to cognitive
development typically means a range of
functions could be affected, requiring a
comprehensive battery of cognitive assess-
ments. However, Taylor-Robinson and
colleagues did not give the design of these
cognitive assessments the same weight as
other methodological considerations when
selecting studies for their systematic re-
view. Finally, recovery of cognitive im-
pairments may depend on remedial edu-
cation or psychosocial stimulation in
addition to treatment of the disease
leading to the impairment [11]. Conse-
quently, null results with cognitive out-
comes are difficult to interpret unless trial
designs address the above issues.
When measuring the quantity of school-
ing, it is also critical to directly verify
attendance through independent checks
on site rather than relying on reported
data, which is often influenced by incen-
tives for teachers to exaggerate enrollment
and attendance to increase funding. One
study found large discrepancies between
school attendance measured by registers
versus spot checks in a sample of Kenyan
primary schools, with average attendance
over 10 percentage points higher in the
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included in the review reported negative
findings on attendance [12,13], but both
relied on such secondary data.
Sample Attrition
The impact of deworming on school
participation creates its own methodolog-
ical problem of sample attrition, which
was not adequately addressed in the
studies that were included in the Cochrane
review [3]. For example, one included
study reports test score data for 89% of
students in the treatment group but only
59% in the comparison group [14]. If
fewer test scores are available for pupils in
the comparison group because academi-
cally marginal pupils are more likely to be
absent, then the true impact of deworming
will be underestimated. This attrition bias
might also explain why another study
found no effect of deworming on primary
school attendance after excluding all
periods of extended school absence, per-
haps the very effect they were seeking to
detect [13].
Evidence on Health and
Education
Even without addressing the concerns
about treatment externalities, the Co-
chrane systematic review found that
‘‘[w]eight gain after one dose of anthel-
minth drugs became just significant, and
with confidence intervals that include
potentially important weight gain values’’
[3]. This is despite the notorious difficulty
of detecting change in growth in school-
age children. Another recent systematic
review found that deworming shows a
small effect on anemia where worm
infection is common [15], and another
concludes that ‘‘all (included) studies
showed a benefit [of deworming] for
maternal and child health’’ [16].
A large school-based study addressing
the above methodological issues found
that treatment reduced absence by 7
percentage points, amounting to a 25
percent decline in total absence [6]. (Note
that contrary to the claim in the Cochrane
systematic review, the results in [6] are not
confounded by uncontrolled use of praz-
iquantel. The school participation benefits
of deworming are similarly large and
statistically significant in the study subre-
gion, consisting of 58 primary schools,
where schistosomiasis was largely absent
and where the protocol thus called for
praziquantel not to be provided.)
Costs and Benefits
From an economic policy perspective,
the merits of deworming depend mainly
on whether its long-term impact on
earnings exceeds its cost. Deworming costs
pennies per dose, or about US$0.25 per
child per year with delivery costs, so gains
of a mere fraction of a percent in income
would provide a very high benefit to cost
ratio. Studies designed to pick up such
effect sizes would have to be large and
long-lived, perhaps prohibitively so in the
setting of a randomized controlled trial.
Fortunately, history provides a natural
experiment—the Rockefeller-sponsored
campaign against hookworm in the United
States South in the 1910s. Census data
and difference-in-difference analysis have
been used to examine the interaction effect
of the pre-campaign prevalence of hook-
worm in different parts of the South with
the timing of a mass deworming program
[17]. The study found large gains in
literacy, school attendance, and subse-
quent income among cohorts offered
deworming as children, implying that
persistent hookworm infection in child-
hood depressed eventual educational at-
tainment by 2.1 years and adult income by
40%. The findings imply that worms
accounted for 22% of the large 1900
income gap between the US South and
North. Based on the estimated rate of
return to education in Kenya, deworming
is likely to increase the net present value of
wages by over US$30 per treated individ-
ual, creating a benefit to cost ratio of over
100. Even if these estimates from Kenya
and the US South [17] overstate the
economic returns by an order of magni-
tude, the benefit to cost ratio would be
highly favorable.
Conclusions
Existing evidence indicates that mass
school-based deworming is extraordinarily
cost-effective once health, educational,
and economic outcomes are all taken into
account, and it is thus unsurprising that a
series of studies from the 1993 World
Development Report [18] to the recent
Copenhagen Consensus [19] argue that
treatment of the most prevalent worm
infections is a very high return investment.
A review by the Abdul Latif Jameel
Poverty Action Lab at the Massachusetts
Institute of Technology found that de-
worming was by far the most cost-effective
way to increase primary school participa-
tion [20]. These analyses depend in part
on the impact of deworming on the
biomedical outcomes that are the focus
of the Cochrane systematic review [3], but
they also depend on the implications for
the future development of the individual
and society. Future income is a central
measure of this development. Because
there is strong evidence that obtaining
more education leads to higher adult
income, the effect of deworming on school
participation should be central to any
reasonable policy analysis.
We believe that future iterations of the
Cochrane review that address the three
methodological issues described above and
include more detailed coverage of other
health and non-health outcomes would be
significant contributions for both the
biomedical and social science literatures.
We agree with Taylor-Robinson and
colleagues that more trials would be
valuable but we also believe that, based
on the current evidence, policymakers
who have to make decisions today should
treat those infected with soil-transmitted
helminths.
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